Loading clinical trials...
Loading clinical trials...
AG-013,958 is being studied to treat patients with Age-Related Macular Degeneration. A total of 144 subjects may be enrolled in the trial. Subjects will be male or female at least 55 years of age with...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT06990269 · Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT05803785 · Age-Related Macular Degeneration
NCT01866371 · Stargardts, Retinitis Pigmentosa, and more
NCT07392255 · Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT07440225 · Macular Degeneration, Age-Related Macular Degeneration, and more
Pfizer Investigational Site
Mesa, Arizona
Pfizer Investigational Site
Oro Valley, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions